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Abstract
Lung-resident (LR) mesenchymal stem and stromal cells (MSCs) are key elements of the
alveolar niche and fundamental regulators of homeostasis and regeneration. We interro-
gated their function during virus-induced lung injury using the highly prevalent respiratory
syncytial virus (RSV) which causes severe outcomes in infants. We applied complementary
approaches with primary pediatric LR-MSCs and a state-of-the-art model of human RSV
infection in lamb. Remarkably, RSV-infection of pediatric LR-MSCs led to a robust activa-
tion, characterized by a strong antiviral and pro-inflammatory phenotype combined with
mediators related to T cell function. In line with this, following in vivo infection, RSV invades
and activates LR-MSCs, resulting in the expansion of the pulmonary MSC pool. Moreover,
the global transcriptional response of LR-MSCs appears to follow RSV disease, switching
from an early antiviral signature to repair mechanisms including differentiation, tissue
remodeling, and angiogenesis. These findings demonstrate the involvement of LR-MSCs
during virus-mediated acute lung injury and may have therapeutic implications.
Author summary
This work identifies a novel function of lung-resident MSCs during virus-induced acute
lung injury. These findings contribute to the understanding of host response and lung
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repair mechanisms during a highly prevalent clinical situation and may have therapeutic
implications.
Introduction
The ability of organs to maintain homeostasis and regenerate following injury is vital to an
organism. These processes are maintained by many supportive cells including tissue-resident
mesenchymal stem and stromal cells (MSCs). MSCs are found in nearly every vascularized tis-
sue including the upper and lower respiratory tract. More specifically, they are localized in
perivascular niches of small and larger blood vessels and were shown to be lung-resident [1–
7]. In the alveolar niche, lung-resident (LR)-MSCs can interact with epithelial cells and pro-
mote alveolar cell growth, differentiation, and self-renewal. This is of particular importance
for epithelial maintenance as well as for repair and regeneration as demonstrated in artificial
rodent models of lung injury [8–10]. Failure of these mechanisms may play a role in the etiol-
ogy of several chronic lung diseases [11,12]. LR-MSCs can directly interact with various pul-
monary immune cell populations via cellular contact or in a paracrine manner by secretion of
soluble factors [13]. Characterization of immunomodulatory properties of mesenchymal cells
are of great clinical importance since non-resident MSCs are the subject of cell-based treat-
ment approaches for various lung disorders [14,15].
The human respiratory syncytial virus (RSV) is of high prevalence and causes a huge bur-
den on public health systems. Globally, RSV is the leading cause of severe acute lower respira-
tory tract infections in early childhood and suspected to have an underestimated impact on the
elderly [16,17]. Several animal models have been established to study RSV infection, with the
lamb model best reflecting anatomical and immunological properties of the neonatal human
lung. This model recapitulates the clinical features of the human pediatric disease and the
closely related bovine RSV is a natural pathogen of ruminants. Furthermore, unlike rodents,
lambs present a similar lung development, are susceptible to human RSV, and develop compa-
rable pulmonary lesions [18–20].
Despite intense research on MSCs, no information is available about their role during acute
respiratory infection and their contribution following virus-induced injury. Given the impor-
tant role of the mesenchymal compartment and LR-MSCs in lung regeneration and repair, we
hypothesize that this applies during respiratory virus infection. Therefore, we aimed to explore
the role of the pulmonary mesenchymal compartment, in particular LR-MSCs, during RSV
infection using an experimental approach based on primary LR-MSCs isolated from human
pediatric donors and a translational model of human RSV infection in lamb.
Results
LR-MSCs are highly permissive to RSV infection
To study the immunobiology of LR-MSCs during respiratory virus infection, we determined
first if these cells are susceptible towards RSV infection in comparison to a well described cel-
lular target of RSV, namely airway epithelial cells (AECs) [21–23]. We characterized the
LR-MSCs isolated from pediatric donors according to the three criteria proposed by the Mes-
enchymal and Tissue Stem Cell Committee of the International Society for Cellular Therapy
[24]. As shown in Fig 1A, LR-MSCs were positive for the three MSC surface markers CD73,
CD90, and CD105. Additionally, we confirmed plastic adherence of the cells and their triline-
age potential by differentiating them towards chondrocytes, osteocytes, and adipocytes (Fig
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Fig 1. LR-MSCs are highly permissive to RSV infection. (A) Representative histograms showing expression of the
surface markers CD73, CD90, CD105 on pediatric LR-MSCs. (B) Representative phase-contrast (PC) micrograph
showing morphology in culture and demonstrates plastic adherence. Representative images of Toluidine blue, Alizarin
Red S, and Oil Red O stainings after chondrogenic (C), osteogenic (O), and adipogenic (A) differentiation, respectively.
Magnification 40X (PC, O) and 200X (C, A). (C) mRNA expression levels of RSV receptors relative to 106 18S. A Mann-
Whitney U test was applied to compare the two cell types (AECs versus LR-MSCs). Boxplots indicate the median value
(centerline) and interquartile ranges (box edges), with whiskers extending to the lowest and the highest values. Each
symbol represents an individual donor (n = 5). �p<0.05, ��p<0.01. (D) Intracellular viral loads in AECs and LR-MSCs
over time following infection with RSV-A2 at a MOI of 1 PFU/cell expressed as RSV copies per 1012 18S copies. Each
symbol represents an individual donor (n = 5). (E) RSV F-protein positive LR-MSCs assessed by FCM and plotted over
time. LR-MSCs were infected with 0.1 PFU/cell with RSV-A2 (n = 3) or a clinical isolate RSV-ON1-H1 (n = 4–6). Each
symbol represents an individual donor. (F) Representative live-cell imaging of WD-AECs and LR-MSCs infected with
0.1–0.5 PFU/cell with RSV-mCherry and followed over time. The micrographs were taken at 16, 32, and 48 h p.i. in the
same area of the cellular layer. (G) Representative confocal microscopy evaluation of LR-MSCs noninfected (mock) or
infected with RSV-A2 at 1 PFU/cell 24 to 72 hours p.i. RSV, green; DAPI, dark blue; WGA, white. Scale bar, 20 μm. (H)
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1B). Next, we assessed mRNA expression levels of different putative RSV cell-surface recep-
tors/co-receptors [25–30], namely nucleolin, toll-like receptor 4 (TLR4), intercellular adhesion
molecule 1 (ICAM-1), annexin II, and CX3CR1 in pediatric LR-MSCs in comparison to
donor-matched AECs. All tested receptors were expressed in both cell types at various levels
(Fig 1C), suggesting that LR-MSCs are susceptible to RSV infection. Thereby, we detected fast
replication kinetics of RSV RNA in LR-MSCs similar to levels measured in infected AECs (Fig
1D). To confirm the replication of RSV in LR-MSC, we next used a flow cytometry (FCM)
approach. We infected LR-MSCs with a clinical isolate of RSV subtype A (RSV-ON1-H1) and
with RSV-A2 at low multiplicity of infection (MOI; 0.1 PFU/cell). After 144 hours post-infec-
tion (p.i.) 40–100% of LR-MSCs were infected depending on the donor (Fig 1E). However,
when using higher MOIs (1 PFU/cell), 144 hours p.i., both RSV-A2 and RSV-ON1-H1
infected nearly 100% of the cells (S1A Fig). Given that LR-MSCs are highly susceptible to RSV
infection, we were wondering how the virus spreads among the cells. To follow visually virus
spread in the two different cell types, we performed live imaging in specific areas of the cellular
layer following infection with a recombinant RSV construct expressing constitutively the
mCherry reporter (RSV-mCherry). While infected well-differentiated (WD)-AECs appear as
discrete RSV-positive cells, infected LR-MSCs showed up in discrete foci, suggesting RSV
spread via cell-to-cell contact (Fig 1F). In order to confirm that the increase of mCherry
reporter signal in LR-MSCs foci is due to RSV spread, we infected LR-MSCs with RSV-A2 and
visualized the presence of RSV over time using a high definition confocal microscopy
approach. Notably, while the RSV signal was often located at the plasma membrane at 24h p.i,
it increased over time and became mainly perinuclear and/or cytosolic at later time points,
suggesting replication (Fig 1G). To further confirm the distinct life cycles, we measured infec-
tious virus release over time in LR-MSCs in comparison to WD-AECs by applying a plaque-
forming unit (PFU) assay. Remarkably, at most of the time-points tested, there was signifi-
cantly higher infectious virus release in the apical washes of infected WD-AECs compared to
the supernatants of infected LR-MSC cultures. Moreover, while there was almost no infectious
virus detectable in the supernatants of LR-MSCs with both MOIs tested (Figs 1H and S1B), we
observed an exponential increase of the intracellular infectious RSV titers over time at both
MOIs tested (Figs 1I and S1C). Finally, when assessing the extracellular viral RNA loads in
WD-AECs in comparison to LR-MSCs, we observed a rapid exponential increase of virus
loads in the apical washes of WD-AECs and rather an accumulation of RSV RNA in the super-
natants of LR-MSCs, suggesting the presence of substantial levels of non-infectious RSV parti-
cles (Figs 1J and S1D). Altogether, these results demonstrate that primary pediatric LR-MSCs
are highly permissive to RSV infection and that RSV replicates in LR-MSC, although the life
cycle of RSV is distinct to AECs.
RSV infection is altering the immune properties of LR-MSCs
We aimed to establish if LR-MSCs can mount an antiviral response upon RSV infection.
Twenty-four hours p.i., we observed a significant increased expression of interferon stimulated
Supernatants of infected LR-MSCs or apical washes of infected WD-AEC cultures were analyzed by a PFU assay. Cells
were infected with RSV-ON1-H1 at a MOI of 0.1 PFU/cell. A Mann-Whitney U test was applied to compare the two
cell types (WD-AECs, n = 3 versus LR-MSCs, n = 5–6). Each symbol represents an individual donor. �p<0.05,
��p<0.01. (I) Intracellular infectious RSV titers in LR-MSCs infected with RSV-A2 or RSV-ON1-H1 at 0.1 PFU/cell.
Each symbol represents an individual donor (n = 3) (J). Extracellular RSV RNA load over time in supernatants of
infected LR-MSCs or apical washes of infected WD-AEC cultures. Cells were infected with RSV-ON1-H1 at a MOI of
0.1 PFU/cell. A Mann-Whitney U test was applied to compare the two cell types (WD-AECs, n = 3 versus LR-MSCs,
n = 4–6). Each symbol represents an individual donor. �p<0.05.
https://doi.org/10.1371/journal.ppat.1009789.g001
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genes (ISGs) commonly induced during RNA virus infections [31]. More specifically, RSV-A2
and RSV-ON1-H1 infection induced a significant upregulation of retinoic acid-inducible
gene-I (RIG-I), melanoma differentiation-associated protein 5 (MDA-5), 2’,5’-oligoadenylate
synthetase 2 (2’,5’-OAS), interferon (IFN)-induced dynamin-like GTPase (MxA), and virus
inhibitory protein, endoplasmic reticulum-associated, IFN-inducible (Viperin) compared to
mock control (Fig 2A). Furthermore, the mRNA levels of both IFN-β and IFN-λ1 had a trend
towards significantly higher levels upon RSV infection (Fig 2B). We also verified if RSV infec-
tion-induced mRNA levels of type I and III IFNs resulted in an increased protein release. IFN-
β release was significantly stimulated by the two RSV strains over time and was quantified at
highly significant levels after 72 hours p.i. (Fig 2C). Furthermore, the protein levels of IFN-λ1/
3 were significantly elevated after 24 and 72 hours p.i. compared to mock control for RSV-A2
and had a trend towards significance for the RSV-ON1-H1 strain (Fig 2D). Notably, infection
of WD-AECs in comparison to LR-MSCs induced comparable IFN type I and III levels 24 to
72 hours p.i., suggesting a similar IFN response upon RSV infection (S2A, S2B, and S2C Fig).
Next, we wanted to evaluate whether infection has an impact on the immunomodulatory prop-
erties of LR-MSCs. First, we evaluated the cell-surface expression levels of two co-stimulatory
molecules, namely programmed death-ligand 1 (PD-L1) and major histocompatibility com-
plex (MHC) class I, described in LR-MSCs to be involved in their immunomodulatory charac-
teristics [32,33]. LR-MSCs expressed baseline levels of both co-stimulators. Poly(I:C), a ligand
mimicking RNA virus infection, induced a significant upregulation of both co-stimulatory
molecules in comparison to mock control. In line with this, RSV infection led to the induction
of slightly increased levels of PD-L1 and MHC class I expression compared to mock-treated
LR-MSCs, with differences not reaching significance, as shown in representative histograms
(S2D Fig) and upon quantification (S2E Fig). Next, we evaluated the secretory profiles of
LR-MSCs following RSV infection in comparison to WD-AECs. Upon infection of WD-AECs
with RSV-A2 or RSV-ON1-H1, the basolateral cytokine secretion revealed mainly CXCL10/
IP-10 and CXCL8/IL-8 release (Fig 2E). Contrary to WD-AECs, RSV infection of LR-MSCs
led to a massive secretion of several cytokines. In fact, 24 and 72 hours p.i., expression was
remarkably increased for most of the cytokines measured, including CXCL10/IP-10, CXCL8/
IL-8, IL-6, G-CSF, CCL5/RANTES, IL-9, IFN-γ, IL-5, and L-17 to name the most notable ones
(Fig 2F). Taken together, these data demonstrate that RSV infection leads to a robust activation
of LR-MSCs, characterized by a strong antiviral and pro-inflammatory phenotype combined
with cytokines modulating T cell function (Fig 2G).
RSV infection is causing lung injury in lamb
To study the MSC compartment of the lung and its role during an acute virus infection, we
applied an in vivo approach using the neonatal lamb model of RSV infection. Although data
are available on ovine MSCs derived from several tissues, ovine LR-MSCs have not been
described yet [34–36]. Thus, we isolated and expanded LR-MSCs cultures from healthy ovine
lung cell suspensions as described previously for human tissue [3]. Characterization by immu-
nophenotyping displayed a high level of cell surface markers typically found in MSCs such as
the hyaluronate receptor CD44 and CD29 (ITGB1). An additional marker, CD166 (ALCAM),
was also expressed on cultured MSCs (S3A Fig). The plastic-adherent cells were large with a
fibroblast-like morphology. Multilineage capacity was confirmed following specific culture
conditions, as ovine LR-MSCs transdifferentiated to chondrocytes, osteocytes, and adipocytes
(S3B Fig). Together, these features fulfill the accepted criteria to identify MSCs proposed by
the Mesenchymal and Tissue Stem Cell Committee of the International Society for Cellular
Therapy [24]. Before infection of the animals, we performed an infection of ovine LR-MSC
PLOS PATHOGENS Role of lung-resident MSCs during RSV infection
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Fig 2. RSV infection is altering the immune properties of LR-MSCs. (A, B) mRNA levels of selected ISGs (A) and IFNs (B)
in LR-MSCs treated with mock control, poly(I:C) 10 μg/ml, RSV-A2, or RSV-ON1-H1 for 24 h at 1 PFU/cell. Boxplots
indicate the median value (centerline) and interquartile ranges (box edges), with whiskers extending to the lowest and the
highest values. Each symbol represents an individual donor (mock, n = 6; poly(I:C), n = 5; RSV-A2, n = 4; RSV-ON1-H1,
n = 6). The data were compared with the Kruskal–Wallis test followed by Dunn’s post hoc test. �p<0.05, ��p<0.01. (C, D)
IFN-β (C) and IFN-λ1/3 (D) protein levels in supernatants of LR-MSCs treated with mock control, poly(I:C) 10 μg/ml,
RSV-A2, or RSV-ON1-H1 for 24 h and 72 h at 1 PFU/cell. Boxplots indicate median value (centerline) and interquartile
ranges (box edges), with whiskers extending to the lowest and the highest values. Each symbol represents an individual
donor (mock, n = 6; poly(I:C), n = 5; RSV-A2, n = 4; RSV-ON1-H1, n = 6). A Kruskal–Wallis test followed by a Dunn’s post
hoc test was applied to compare the different groups. �p<0.05, ��p<0.01, ���p<0.001. The detection limits of the assays are
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cultures with human RSV. Virus replication was evident as observed by an increase of RSV
load of cell-associated viral RNA over time. Similarly to RSV-infected human LR-MSCs, the
infectious virus in the supernatants was undetectable or close to the detection limit suggesting
cell-to-cell spread (S3C Fig). Furthermore, ex vivo infection of ovine precision-cut lung slice
(PCLS) cultures with a recombinant RSV construct expressing constitutively the green fluores-
cent protein (RSV-GFP) led to an increase of the reporter signal over time, indicating replica-
tion (S3D Fig). When analyzing the infected PCLSs at higher magnification, the GFP signal
was mainly located in the alveolar wall suggesting infection of pneumocytes (S3E Fig). New-
born lambs were infected with human RSV-A2 and respiratory disease was evaluated during
the acute (3 and 6 days p.i.), recovery (14 days p.i.), and convalescence (42 days p.i.) phases. To
do so, at each timepoint p.i., we examined the lung tissue and the cellular components of
bronchoalveolar lavage (BAL) fluid (Fig 3A). RSV-infected neonates showed clear nasal dis-
charge, occasional coughing and wheezing. Macroscopic lesions were detected at necropsies
performed 3 and 6 days p.i. Lungs failed to collapse and showed multiple, irregular, mildly red-
dened areas with slightly increased consistency of up to 2 cm in diameter in all lung lobes. His-
topathological evaluation of the lungs revealed tissue consolidation, bronchiolitis, and
thickening of interalveolar walls 3, and 6 days following RSV infection (Fig 3B). Following
infection, alveolar type 2 cell hyperplasia was observed, indicating tissue injury (S4A Fig). In
addition, at 6 days p.i. we observed occasionally potential syncytial cells lining alveoli (S4A and
S4B Fig). These features disappeared 14 days p.i. (Fig 3B), indicating resolution of lesions after
RSV-mediated acute lung injury. Immunohistochemistry analysis of lung tissue sections
revealed the presence of RSV antigen in pneumocytes (Fig 3C). We evaluated the viral RNA
levels in the lung and BAL tissues. In the lung, the RSV loads decreased over time with no
virus detectable in 50% of the animals 14 days p.i. and in all animals 42 days p.i. In the cellular
fraction of the BAL, RSV copies were highest at 3 days p.i., with viral RNA detectable in 66%
of the animals 14 days p.i. and reaching undetectable levels 42 days p.i. There was a significant
difference in viral loads with approximately 100 times higher level of RSV copies detectable in
the BAL compartment compared to the lung at both, 3 and 6 days p.i. (Fig 3D). To confirm the
histopathological evaluation revealing RSV-mediated tissue injury, we assessed cell death by
quantifying cleaved caspase-3-positive cells using an approach summarized in S5 Fig. The per-
centage of cleaved caspase-3 positive cells in the lung, was significantly increased for infected
animals 3, and 6 days p.i. and similar 14, and 42 days p.i. compared to mock controls (Fig 3E).
Lung injury is further indicated by shedding of apoptotic cells into the bronchoalveolar space.
Indeed, there are significantly more cleaved caspase-3 positive cells 3 days p.i. assessed for
infected compared to mock-infected animals (Fig 3F). The impact of RSV infection on the
bronchoalveolar space is further indicated by an infiltration of cells as assessed in the BALs
from infected compared to mock-infected animals 3 to 14 days p.i. (Fig 3G). In summary, the
life cycle of RSV is similar in human and ovine LR-MSCs and infection of neonatal lambs with
human RSV is causing lung injury. These data support the use of the lamb model to investigate
LR-MSCs in RSV disease.
indicated with the dotted line at 7.7 pg/mL and 79.8 pg/mL for IFN-β and IFN-λ1/3, respectively. (E, F) Multiplex assay of
basolateral medium of WD-AECs (E) or supernatants of LR-MSCs (F), 24 and 72h after treatment with mock control, 10 μg/
ml poly(I:C), RSV-A2, or RSV-ON1-H1 for 24h and 72h at 1 PFU/cell. The concentration ranges of the different cytokines
are indicated (lower detection limit-highest concentration measured). An asterisk is present when the concentration of the
sample was higher than the upper range of the assay. Each column represents a different donor (mock, n = 6; poly(I:C),
n = 5; RSV-A2, n = 4; RSV-ON1-H1, n = 6; donors a-c for WD-AECs and d-i for LR-MSCs). (G) Overview of the impact of
RSV infection on LR-MSCs. RSV-mediated activation of LR-MSCs is characterized by an antiviral and pro-inflammatory
phenotype combined with cytokines promoting T helper cell (Th) polarization.
https://doi.org/10.1371/journal.ppat.1009789.g002
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LR-MSCs are a target for RSV infection in vivo
To determine if LR-MSCs can be a target for RSV in vivo, we designed an FCM assay allowing
the identification of the pulmonary epithelial (CD31-CD45-panCTK+) and mesenchymal
(CD31-CD45-panCTK-CD29+CD44+) compartments, as well as detection of RSV infection in
vivo (Fig 4A). In 13–80% of the infected animals, both RSV-positive epithelial cells and
LR-MSCs were detected in the lung cell suspensions 3, 6 and 14 days p.i. (Figs 4B and S6).
When RSV-positive LR-MSCs were plotted as a function of RSV-positive epithelial cells, a sig-
nificant positive association was found, suggesting that the spread of RSV infection to
LR-MSCs is linked to the extent of replication in the pulmonary epithelium (Fig 4C). Next,
MSCs derived from lung tissue and BALs, were isolated from each animal at the different time
Fig 3. RSV infection is causing lung injury in lamb. (A) Newborn animals were trans-tracheal inoculated with 108
PFU per animal of the human strain RSV-A2 or PBS (mock). Animals were euthanized 3, 6, 14, and 42 days p.i. and
lung and BAL tissues were harvested for histopathological evaluation, qPCR, and FCM analysis (B) Representative H&E
stained histopathological sections of the lung tissue from noninfected (mock) and RSV-infected lambs at 3, 6, 14, and 42
days p.i. Scale bar, 200 μm. (C) Histological lung sections from animals 6 days p.i. stained for RSV (red) and
counterstained with haematoxylin (blue). From left to right panels, scale bars 50 μm, 100 μm and 20 μm, respectively.
(D) Viral load in lungs and the cellular fraction of the BAL of infected lambs measured 3, 6, 14, and 42 days p.i.
Comparison of viral loads between BAL and lung tissues was done with a one-way ANOVA and the Tukey post-hoc
test. Each symbol represents an individual animal (n = 6 per timepoint). �p<0.05. (E, F) Frequency of cleaved caspase 3
(CASP3)-positive cells in the lung (E) and BAL (F) of infected animals 3 to 42 days p.i. Boxplots indicate the median
value (centerline) and interquartile ranges (box edges), with whiskers extending to the lowest and the highest values.
Each symbol represents an individual animal (mock, n = 3 and RSV, n = 6). Multiple comparison was done with a one-
way ANOVA and the Tukey post-hoc test. �p<0.05. (G) Total BAL cell counts in mock and RSV-infected animals 3, 6,
and 14 days p.i. pooled. Boxplots indicate the median value (centerline) and interquartile ranges (box edges), with
whiskers extending to the lowest and the highest values. Each symbol represents an individual animal (n = 9, mock and
n = 18, RSV). A Mann-Whitney U test was applied to compare the two groups. ��p<0.01.
https://doi.org/10.1371/journal.ppat.1009789.g003
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points p.i. and expanded in culture. When testing the presence of RSV within the lung-derived
MSC cultures, viral RNA was detectable in most cultures from the animals at 3 and 6 days p.i.
and in none of the cultures isolated from animals at 14 and 42 days p.i. In line with the higher
viral loads in the BAL cellular fraction compared to the lung tissue, we detected high levels of
RSV RNA in all BAL-derived MSCs from animals at 3 and 6 days p.i. and from 3 out of 7 ani-
mals isolated at 14 days p.i. RSV RNA levels were undetectable in all cultures isolated from ani-
mals at 42 days p.i. (Fig 4D). Interestingly, we noticed giant multinucleated cells in cultures
derived from infected animals which were never seen for mock animal-derived cultures (Fig
4E). Given that RSV spread in foci and infectious virus was rarely detected in the supernatants
of infected human and ovine LR-MSCs cultures, we hypothesized that these phenotypically
distinct cells were RSV-infected MSCs. This was confirmed by confocal microscopy
Fig 4. LR-MSCs are a target for RSV infection in vivo. (A) FCM gating strategy to identify RSV-infected epithelial
cells (CD31-CD45-panCTK+) and LR-MSCs (CD31-CD45-panCTK-CD29+CD44+). panCTK, pan-cytokeratin; G1,
gate 1. (B) Percentage of animals with RSV-positive epithelial and LR-MSCs 3 to 42 days p.i. The fractions indicate the
number of infected animals where infection was detected by FCM compared to the total number of animals. (C)
Correlation of RSV-positive LR-MSCs and RSV-positive epithelial cells at 3 and 6 days p.i. Associations were tested
using the Spearman rank correlation test. Each symbol represents an individual animal. (D) RSV loads in MSCs
isolated from lung and BAL tissues of RSV-infected animals 3, 6, 14, and 42 d p.i. and expanded in culture. Each
symbol represents an individual animal (n = 6–8). The filled dashed box indicates the samples below detection limit.
(E) Phase-contrast micrographs of LR-MSCs derived from BALs expanded in culture from noninfected (mock) or
infected (RSV) animals 3 days p.i. Magnification 100X. The yellow arrowheads indicate a cluster of nuclei of a potential
syncytium. (F) Representative confocal microscopy evaluation of LR-MSCs derived from BALs expanded in culture
from noninfected (mock) or infected (RSV) animals 3 days p.i. RSV, orange; DAPI, dark blue; WGA, light blue. Scale
bars, 15 μm (left and middle panels) and 10 μm for the 3D capture (right panels).
https://doi.org/10.1371/journal.ppat.1009789.g004
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visualization (Fig 4F) and by the infection of cultures from human and ovine LR-MSCs with
RSV-mCherry (S7A and S7B Fig). Together, these results indicate that the lung MSC compart-
ment is a target for RSV infection in vivo during the early phase of respiratory disease.
RSV infection leads to the expansion of the pulmonary MSC niche in vivo
To investigate the impact of virus-mediate lung injury on LR-MSCs in vivo, we analyzed the
mesenchymal compartment of RSV-infected newborn lambs during the acute, recovery, and
convalescence phases of RSV disease. As a mild to asymptomatic RSV disease control, adult
animals were infected for a period of 14 days (Fig 5A). Contrary to RSV-infected neonates,
infection of adults did not lead to any notable clinical manifestation nor macroscopic lesions,
while rare foci of interstitial thickening with leukocyte infiltrates and mild alveolar type 2
hyperplasia were visible histologically (Fig 5B). A colony-forming unit-fibroblast (CFU-F)
assay was applied to lung-derived cells from infected and mock-infected animals. This assay is
commonly used to assess the proliferative activity of MSCs and their ability to form discrete
fibroblast-like colonies [37,38]. The analysis revealed a significant effect of RSV infection on
the proliferative properties of LR-MSCs by increasing their activity already 3 days p.i. com-
pared to mock control (Fig 5C). Quantitative analysis confirmed significantly increased
CFU-F counts during the acute phase of infection 3 and 6 days p.i. Interestingly, there was still
a nonsignificant tendency of more CFU-F counts during later phases of RSV disease 14 and 42
days p.i. compared to age-matched non-infected animals (Fig 5D). CFU-F counts were around
Fig 5. RSV infection leads to the expansion of the pulmonary MSC niche in vivo. (A) Newborn or adult (average age
of 29 months) animals were trans-tracheal inoculated with 108 PFU per animal of the human strain RSV-A2 or PBS
(mock). Newborns were euthanized 3, 6, 14, and 42 days p.i. and adults 6 and 14 days p.i. and lung tissue was harvested
for CFU-F assay. Lung tissue of adults was harvested for histopathological evaluation (B) Representative H&E stained
histopathological sections of the lung tissue from noninfected (mock) and RSV-infected adults at 6 and 14 days p.i. scale
bar, 200 μm. (C, E) Representative images of the CFU-F assay for mock control and RSV-infected neonates (C) and
adults (E) 3 to 42 days p.i. and 6 and 14 days p.i., respectively. Each image represents an individual animal. (D, F)
Quantification of the CFU-F assay for each neonate (D) and adult (F) animals, given as CFU-F count relative to 3.33X105
nucleated cells over time. Boxplots indicate the median value (centerline) and interquartile ranges (box edges), with
whiskers extending to the lowest and the highest values. Each symbol represents an individual animal (neonates, per
timepoint: mock, n = 3–4; RSV, n = 6–8; adults: mock, n = 14; RSV, n = 3 per timepoint). A one-way ANOVA and the
Holm-Sydak post-hoc test was applied to compare differences between groups. �p<0.05, ���p<0.001, ����p<0.0001.
https://doi.org/10.1371/journal.ppat.1009789.g005
PLOS PATHOGENS Role of lung-resident MSCs during RSV infection
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1009789 July 28, 2021 10 / 28
20 times lower for control adults (average CFU-F count of 0.6) in comparison to control neo-
nates (average CFU-F count of 14.2), indicating an age-dependent effect on the steady-state
proliferative properties of LR-MSCs. However, RSV infection led to a significant increase of
these colonies 14 days p.i. with an average count of 6.3 (average CFU-F count of 29.9 for
infected neonates 14 days p.i.) (Fig 5E and 5F). These results provide evidence that RSV infec-
tion leads to a stimulation of the proliferative activity and the expansion of the pulmonary
MSC pool, particularly in neonates compared to older animals.
The transcriptional activity of LR-MSCs is related to the phases of RSV
disease
To investigate how RSV infection impacts LR-MSCs at the transcriptional level in vivo, we
applied an experimental approach developed by Spadafora et al., who showed that tracheal
aspirate-derived MSCs retain their transcriptional signature following a short expansion in
culture [39]. We undertook whole transcriptome analysis from expanded LR-MSCs isolated
from infected neonates during the acute, recovery and convalescent phases of RSV disease in
comparison to mock-infected neonates. To confirm identity of MSCs expanded in culture, we
calculated the transcripts per million (TPM) of markers used for their identification [24,40].
LR-MSCs had high transcriptional levels of ENG (CD105), NT5E (CD73), THY1 (CD90),
ITGB1 (CD29), CD44 and PDGFRA among others, and lacked transcripts of HLA-DR or
HLA-DQ, PTPRC (CD45), CD34, ITGAM (CD11b), or PECAM (CD31) confirming their
MSC identity (Fig 6A). Next, we compared the transcriptome profiles of LR-MSCs during the
acute phase of RSV disease (6 days p.i.) to mock-infected animal-derived LR-MSCs and found
14 differentially expressed genes (DEGs) to be significantly upregulated. The majority of them
belong to the IFN pathway and are associated with antiviral responses, such as RSAD2
(Viperin), OASL, ISG15, IFI44, and IFI44L and two pro-apoptotic genes, namely TNFSF10/
TRAIL and STC1 (Fig 6B). These findings are in line with our in vitro results derived from
human LR-MSC and support the idea that LR-MSCs mount an antiviral response against RSV
infection in vivo. Remarkably, while there was no significant difference in the recovery phase
(14 days p.i.) compared to mock-infected control (Fig 6C), there were 43 DEGs in LR-MSCs
isolated during the convalescence phase (42 days p.i.) (Fig 6D). Several of these genes are asso-
ciated with the secretory pathway, including MAGE2 (protein trafficking), TBC1D20 (autop-
hagosome maturation), MAP7D3 (microtubule assembly), and MARCHF9 (protein
processing). In line with this, high transcriptional activity of LR-MSCs during the convales-
cence phase is evidenced by the upregulation of various non-coding RNAs and ribonuclease
proteins involved in pre-RNA processing and regulation of transcription and/or translation.
Furthermore, genes linked with differentiation and developmental processes, such as SOX4,
NOC3L, and C2CD3 were differentially expressed during the convalescence phase. Remark-
ably, many of the upregulated DEGs were related to endothelial cell function and angiogenesis,
such as TRPC4 or KDR which codes for the vascular endothelial growth factor receptor 2
(VEGFR2), and ITGA9, the receptor of VCAM1. Finally, among the top downregulated DEGs
were two genes coding for matrix-metalloproteases (MMPs), MMP1 and MMP3, which are
involved in the remodeling of the extracellular matrix (ECM). The list of significant DEGs and
associated literature from infected versus noninfected animal-derived LR-MSCs is provided in
S1 Table. To confirm the interpretation of our findings, we used a computational method for
pathway enrichment analysis of the transcriptional profiles of LR-MSCs over RSV infection.
Gene set enrichment analysis (GSEA) revealed that the transcriptional signature of LR-MSCs
isolated from RSV- and mock-infected animals is retained during the short ex vivo culture
phase and is following the different phases of respiratory disease. During the acute phase of
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infection, the significant enriched hallmark gene sets were associated to IFN pathway, inflam-
mation, and stress response. Notably, the only enriched gene set downregulated in the acute
phase of RSV infection was Notch signaling, a central pathway regulating cell proliferation and
differentiation. During the recovery and the convalescence phases, shared gene sets associated
with cell cycle regulation, such as E2F and Myc pathway, were downregulated compared to
mock controls. Further, during the convalescence phase of RSV disease, five additional hall-
mark gene sets were upregulated. More precisely, the transcriptional signature of LR-MSCs
isolated from infected animals long after viral clearance revealed processes such as myogenesis,
epithelial-mesenchymal transition (EMT), angiogenesis, p53 pathway, and TGF-β signaling,
suggesting that LR-MSCs are involved in tissue repair and regeneration following virus-
induced injury (Fig 6E). To sum up, these results show that LR-MSCs are activated during
virus-induced lung injury by an increase in their proliferative activity and by mounting
dynamic transcriptional profiles leading to an early antiviral and inflammatory response fol-
lowed by mechanisms associated with tissue remodeling, repair and regeneration (Fig 6F).
Fig 6. The transcriptional activity of LR-MSCs is related to the phases of RSV disease. (A) Expression levels of selected
classical MSC markers expressed as log2TPM (TPM, transcripts per million). Each column is a different time p.i. (6, 14, and 42
days p.i.). (B-D) Volcano plots of the DEGs from the comparison of RSV infection and mock control 6 (B), 14 (C), and 42 (D)
days p.i. with padj<0.05 (red filed circles). (B) Pie chart with the 14 DEGs 6 days p.i. (padj<0.05) categorized according to their
function. (D) Pie chart with the 43 DEGs 42 days p.i. (padj<0.05) categorized according to their function. (E) Normalized
enrichment score of significant (false discovery rate, FDR<0.05) hallmark gene sets for the comparisons of RSV infection and
mock control 6, 14, and 42 days p.i. (downregulated, blue and upregulated, red) (F) Illustration summarizing the different
functions of LR-MSCs over the course of RSV disease.
https://doi.org/10.1371/journal.ppat.1009789.g006
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Discussion
This work was undertaken to explore the role of the pulmonary MSC compartment during
acute respiratory virus infection and its contribution to lung repair. Our investigations herein
reveal upon infection, LR-MSCs mount an antiviral response and release a variety of immuno-
modulatory mediators, which may have a biological impact on the pulmonary microenviron-
ment. Furthermore, we show that RSV-mediated lung injury activates and stimulates the
expansion of LR-MSCs which mount a dynamic transcriptional program related to mecha-
nisms of repair and regeneration.
Contrary to the well-described replication of RSV in AECs, the primary cellular target of
RSV infection [21–23], our data indicates a distinct life cycle in LR-MSCs with viral spread via
cell-to-cell contact. Such mechanism may improve virus dissemination and promote immune
evasion [41]. In a humanized mouse model, pulmonary mesenchymal cells were shown to be
susceptible to different viruses such as Middle East respiratory syndrome coronavirus, Zika
virus, and cytomegalovirus [42]. In addition, they were recently proposed as an immune-privi-
leged niche for M. tuberculosis persistence [43]. Since LR-MSCs are described to localize peri-
vascular and in close proximity to the respiratory and alveolar epitheliums, this makes them a
potential nonepithelial target for virus infection. Here, we show accessibility of LR-MSCs pos-
sibly through physical disruption of the alveolar epithelium. Indeed, already 3 days p.i., we
observed evidence of lung injury associated with alveolar infection and concomitant LR-MSCs
targeting by the virus. RSV infections can lead to a number of extrapulmonary manifestations
[44]. Assuming the presence of MSCs in most tissues, it is conceivable that in some circum-
stances, RSV may target other MSC niches throughout the body. In line with this, bone mar-
row and umbilical cord vein MSCs were shown to be susceptible to RSV infection in vitro
[45,46].
During the acute phase of RSV disease, we observed RSV-positive multinucleated LR-MSCs
in the BAL-expanded cultures, indicative of a cytopathic effect on these cells. Thereby, the con-
comitant expansion of the pulmonary MSC compartment is potentially indicative of a replen-
ishment of the lost fraction of LR-MSCs following RSV infection. Furthermore, we show that
RSV infection is signaled by LR-MSCs through the induction of antiviral and pro-inflamma-
tory mediators, both associated with RSV disease severity [47–49]. In addition, RSV infection
of LR-MSCs led to a type I and III IFNs release and ISGs induction, shifting LR-MSCs towards
an antiviral state. This is in line with the pro-inflammatory and antiviral transcriptional signa-
tures found in LR-MSCs, isolated from infected animals during the acute phase of RSV disease.
In mice, it has been shown that IFN signaling of the lung stromal compartment was protective
against influenza virus by reducing viral replication [50]. Massive lung infiltration of immune
cells following cytokine release, termed “cytokine storm”, is characteristic of severe respiratory
virus infections including RSV [51]. Among the most abundant chemokines in infants suffer-
ing from RSV bronchiolitis are CXCL10/IP-10, CXCL8/IL-8, CCL2/MCP-1 and CCL3/MIP-
1α. Similarly, in our setting, RSV infection of LR-MSCs led to a massive release of chemokines
with the potential to attract neutrophils, eosinophils, monocytes, and lymphocytes, such as
CXCL8/IL-8, CCL5/RANTES, CCL2/MCP-1, and CXCL10/IP-10, respectively. In RSV dis-
ease, it is believed that the cellular sources of the pulmonary chemokine responses are epithe-
lial and inflammatory immune cells; our data suggests that LR-MSCs might provide an
additional source [52].
Besides the vast chemokine production, RSV infection of LR-MSCs led as well to the release
of a number of other mediators and growth factors. Interestingly, the secretory profile of RSV-
infected LR-MSCs was very distinct to the one described for RSV infected BM-MSCs, support-
ing tissue specificity of MSC populations [45,53,54]. Notably, VEGF, a key mediator of
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angiogenesis, is released by pediatric LR-MSCs at increased levels after RSV infection. Also,
the transcriptional profiles of LR-MSCs isolated during the convalescence phase of RSV dis-
ease were related to endothelial biology and pathway analysis revealed pro-angiogenic
enriched gene sets. In line with this, using an adult rat model, VEGF signaling disruption was
shown to cause an enlargement of the air spaces and an alteration of the alveolar structure,
suggesting that VEGF has a crucial role during normal adult alveolarization [55]. Considering
the perivascular location of MSCs in tissues, our data indicate that LR-MSCs may modulate
endothelial cell activity during virus-induced lung injury.
TGF-β is a central regulator of the respiratory system and controls epithelial and mesenchy-
mal cell fate through several mechanisms such as promotion of EMT, myofibroblast differenti-
ation, and stimulation of ECM production and remodeling [56]. Our transcriptional data
from LR-MSCs isolated from infected animals during the convalescence phase of RSV disease,
revealed that these cells might play a role in these mechanisms. Indeed, compared to nonin-
fected control-derived LR-MSCs, their transcriptome profiles are linked with TGF-β signaling
and EMT. The latter is linked with the acquisition of more proliferative stem-like states provid-
ing an additional link between activation of EMT and wound healing [57]. In line with this,
the p53 pathway activation further supports the maintenance of MSC stemness for subsequent
repair processes [58]. Transcriptome analysis of LR-MSCs isolated long after virus clearance,
positively associated with myogenesis. Myofibroblasts, an activated type of mesenchymal cells
and an important source of ECM, participates in tissue repair but their persistence after
wound healing is linked to fibrotic disorders [59]. Thus, failure of these mechanisms may
potentially increase the risk of developing fibrotic abnormalities following respiratory virus
infections. Comorbidities such as recurrent wheezing and asthma are happening years after
RSV infection has resolved. To date, it remains unclear if pulmonary mesenchymal cells defi-
ciency in lung repair and regeneration are linked with such disorders [60,61].
Due to their immunomodulatory properties, MSCs are applied in cell-based therapies with
promising outcomes for the treatment of pulmonary morbidities such as idiopathic pulmonary
fibrosis (IPF), acute-respiratory distress syndrome (ARDS) and severe influenza infections
[14,62–65]. Furthermore, the current coronavirus disease 2019 (COVID-19) pandemic is lead-
ing to a strong interest in MSCs as a treatment option for severe COVID-19 cases. As a conse-
quence, an increasing number of clinical investigations of such MSC-based therapy
approaches are under evaluation [66–69]. Safety concerns regarding susceptibility of MSCs
towards different viruses, as well as potential viral reactivation events have been raised [70].
On one hand, our data indicate potential safety concerns due to the targeting of LR-MSCs dur-
ing the acute phase of virus infection. On the other hand, we provide evidence that LR-MSC
seem to have a beneficial effect after virus clearance, supporting the use of MSC-based thera-
pies to treat virus-induced lung injury.
The ovine lung is a classical model of the human respiratory tract due to similarities in size,
structure, development and immune system [71]. However, some limitations should be men-
tioned. First, we observed a high animal-to-animal variability in most endpoints measured,
probably due to the outbred nature of the animals. While this might look like a limitation, we
believe it reflects best the situation in humans compared to inbred models. Secondly, we used
the isolated LR-MSCs as a single population but previous single-cell transcriptomic studies
demonstrated that MSC, are a rather heterogeneous population composed of distinct MSC
subsets [8,9,72]. Third, due to the lung size, we analyzed three pooled specimens, representa-
tive of each lung region. This might explain why we didn’t detect RSV-positive cells for some
animals for whom infection was demonstrated by the assessment of the viral loads.
In summary, our data demonstrate the involvement of pulmonary MSCs during respiratory
virus infection. While being a target for RSV, these cells can respond to infection by switching
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to an antiviral state and by a profound remodeling of their immune phenotype. Furthermore,
LR-MSCs show hallmarks of tissue repair and regeneration processes after viral clearance. Our
findings identify a function of LR-MSCs in a highly prevalent clinical situation and constitute




The experiments with lambs were performed in compliance with the Swiss animal protection
law (TSchV SR 455.1; TVV SR 455.163). They were reviewed by the cantonal committee on
animal experiments of the canton of Bern, Switzerland and approved by the cantonal veteri-
nary authority with the license number BE125/17 (Amt für Landwirtschaft und Natur
LANAT, Veterinärdienst VeD, Bern, Switzerland). For the isolation of the RSV-ON1-H1
strain, the caregivers gave informed consent for the donation of nasopharyngeal aspirates, and
all steps were conducted in compliance with good clinical and ethical practice and approved
by the local ethical committee at Hannover Medical School, Germany (permission number
63090/2012). The isolate was passaged up to five times in HEp-2 cells (ATCC, CCL-23). For
the isolation of primary pediatric MSCs, written informed consent was obtained for all the
patients and/or parent/guardian and the study protocol was approved by the local Ethics Com-
mission of the Canton of Bern, Switzerland (KEK-BE:042/2015).
Virus propagation and titration
Human RSV-A2 strain was derived from ATCC (VR-1540, GenBank accession number
KT992094.1). The recombinant RSV-mCherry is described elsewhere [73] and the RSV-GFP
construct was generated by Mark Peeples (Nationwide Children’s Hospital Columbus, USA)
[74] and kindly provided by Dominique Garcin (University of Geneva, Switzerland). The clini-
cal RSV isolate, RSV-ON1-H1, was isolated from a child below the age of five years with con-
firmed RSV infection, hospitalized at Hannover Medical School, Germany [75]. All RSV
strains were propagated on HEp-2 cells, cultivated in DMEM (Gibco) supplemented with 10%
fetal bovine serum (FBS, Gibco). Briefly, HEp-2 cells were infected at a MOI of 0.02 PFU/cell
for 2 hours before the addition of DMEM supplemented with 5% FBS. The cell-associated
virus was harvested by scraping the cell monolayer when 60% of cytopathic effect was
observed. The virus was released from the cells by one freeze-thaw cycle followed by centrifu-
gation to get rid of cell debris. Virus stocks were stored in aliquots containing 10% sucrose
(Sigma) at -150˚C. To prepare a mock control the same procedure was applied without adding
virus. A similar approach was applied to assess the intracellular RSV titers from infected
LR-MSCs. For virus titration, serial dilutions of supernatants were added to HEp-2 cells and
incubated for 48–96 h at 37˚C, 5% CO2. Next, the cells were washed with PBS, fixed with meth-
anol supplemented with 2% H2O2 and incubated with a biotinylated anti-RSV antibody (Bio-
Rad) in PBS containing 1% bovine serum albumin (BSA, Sigma) for 1 h, followed by 30 min
incubation with ExtrAvidin Peroxidase (Sigma) and staining with 3,30-diaminobenzidine sub-
strate (Sigma). Virus titers were expressed as PFU/ml.
Primary cells
Primary pediatric MSCs were obtained as described previously [32,72]. Briefly, healthy lung
tissue was obtained from pediatric patients undergoing elective surgery for congenital pulmo-
nary airway malformation and other various airway abnormalities (n = 9, age range: 5 days to
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181 months; S2 Table). Minced tissue was further disaggregated enzymatically using a solution
containing collagenase I and II (Worthington Biochemicals) at a concentration of 0.1 and
0.25%, respectively. Further, digestion buffer was supplemented with 0.2 mg/ml deoxyribonu-
clease I (Biochemicals) to the digestion buffer to prevent cell clumps and improve cell recov-
ery. To isolate MSCs, a FCM assay was applied using a panel of fluorescently-conjugated
human monoclonal antibodies: CD45, CD14, CD31, and EpCAM for negative and CD73 and
CD90 for positive selection. FCM-sorted MSCs were expanded in tissue culture flasks pre-
coated with 0.2% gelatin solution (Sigma) and in chemically defined growth medium consist-
ing of α-MEM with ribonucleosides (Sigma) supplemented with 1% FBS, GlutaMAX (Invitro-
gen), 10 ng/ml of recombinant human fibroblast growth factor 2 (FGF2, Life Technologies),
20 ng/ml of recombinant human epidermal growth factor (EGF, Life Technologies), human
insulin (Sigma), 100 units/ml of penicillin and 100 μg/ml streptomycin (Sigma). Cells were
maintained in a humidified atmosphere at 37˚C, 5% CO2 until confluence was reached. The
medium was aspirated carefully and replaced with fresh medium six days after plating and
after that point performed twice a week. Cells were used prior to passage 5 in all experiments.
WD-AECs isolated from independent healthy donors (MucilAir, Epithelix Sàrl, Geneva, Swit-
zerland) were used for RSV infection. The cultures were maintained on 24-well transwell
inserts (Corning) at the air-liquid interface (ALI) in MucilAir culture medium (Epithelix Sàrl,
Geneva, Switzerland) in a humidified incubator at 37˚ C, 5% CO2. Every 3 days culture
medium was changed. The apical surface was rinsed with Hank’s balanced salt solution
(HBSS, ThermoFisher) once a week and prior to infection, to washout the mucus.
Precision-cut lung slices
Isolated ovine lungs were infused with 1.5% low-melting point agarose (Promega) in DMEM
and subsequently put into cold PBS in order to allow the agarose to solidify. Next, the perfused
lung tissue was cut into pieces of 0.1–1 cm3 and embedded in 4% low-melting point agarose.
An automated vibrating microtome (VT1200S, Leica Biosystems) was used at a speed of 0.1
mm/sec and an amplitude of 2.5–2.8 mm to generate PCLS with a thickness of 200 μm. Uni-
formly sized slices were punched at a diameter of 8 mm. The PCLS were maintained in
DMEM, supplemented with 1% FBS, 100 units/ml of penicillin and 100 μg/ml streptomycin,
and 2.5 μg/ml of Amphotericin B (all from ThermoFisher) in a humidified atmosphere at
37˚C, 5% CO2. The culture medium was changed every 24 h and the PCLS cultures were
infected 2–3 days following preparation.
RSV infection
To perform infection of primary pediatric LR-MSCs and AECs with RSV-A2, RSV-mCherry,
or RSV-ON1-H1, 105 cells per well of a 12 well plate were seeded 24 h prior to infection and/or
stimulation. Cells were infected at selected MOIs of RSV or mock-control in FBS-free medium
for 1 h at 37˚C and 5% CO2. Subsequently, cells were washed three times with 1X PBS and
then incubated in growth medium. Ten μg/ml of poly(I:C) (Sigma) was applied in growth
medium and incubated alike until harvesting. At selected time points, supernatants and cells
were harvested and stored appropriately for further analysis. For infection of WD-AECs, virus
preparations were diluted in medium and virus dilutions were applied apically to the tissue,
assuming an average of 500’000 cells per insert. As a mock control, the culture supernatant of
mock-infected HEp-2 cells was used. Virus particles were allowed to adsorb for 3 h at 37˚C
and 5% CO2 before the inoculum was removed and each insert was carefully washed three
times with pre-warmed HBSS and placed on a new well containing fresh MucilAir culture
medium. For stimulation of the WD-AEC inserts, 10 μg/ml poly(I:C) were applied to the
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basolateral chamber containing the culture medium. For examination of infectious viral parti-
cle release 2, 24, 48, 72, and 144 hours p.i., 250 μl HBSS was added to the apical surface and
incubated for 20 min at 37˚C, harvested, and stored at −70˚C until further analysis. Basolateral
media was collected and similarly stored, and replaced with fresh media in the basolateral
chamber of the inserts. For the infection of ovine PCLS, 5x105 PFU of RSV-GFP per PCLS
were applied in growth medium, supplemented with 0.1% FBS and incubated for 24 h at 37˚C
and 5% CO2. Subsequently, the infection medium was changed to growth medium and media
was changed every 24 h.
RNA isolation and quantitative PCR
Total RNA of primary pediatric LR-MSCs, human AECs, and ovine lung- and BAL-derived
cultured MSCs was extracted using the Nucleospin RNA Plus Kit (Macherey-Nagel) according
to the manufacturer’s protocol. For the isolation of the total RNA from the supernatants of
infected LR-MSCs, we used the QIAamp Viral RNA kit following manufactures recommenda-
tions (Qiagen). For reverse transcription and synthesis of complementary DNA the Omnis-
cript RT Kit (Qiagen) using random hexamers (Invitrogen) was applied. Quantitative PCR
was performed with target-specific primers using the TaqMan Gene Expression Assay
(Applied Biosystems) or the Fast SYBR Green Assay (ThermoFisher) on an ABI Fast 7500
Sequence Detection System (Applied Biosystems). For lung tissue and the BAL cellular frac-
tion quantification was performed using AgPath-ID One-Step RT-PCR Reagents (Thermo-
Fisher), according to the manufacturer’s instructions. The data were analyzed using the SDS
software (Applied Biosystems). Relative expression was calculated with the ΔΔCT method
[76]. The expression levels of the genes of interest, were normalized to the housekeeping 18S
rRNA. For the analysis of viral loads, RNA copy numbers were interpolated from a standard
curve generated with the serial dilution of a plasmid containing the cDNA of the RSV L gene
or the housekeeping 18S rRNA. The sequence of all the primers and probes is summarized in
S3 Table.
Flow cytometry
FCM assays using different multicolor staining protocols were applied for the analysis of co-
stimulatory molecule expression and RSV infection of primary pediatric LR-MSCs, for the
identification and analysis of RSV infection of different cell types in lung cell suspensions
derived from lambs, the assessment of apoptosis in the lung and the alveolar space of infected
and mock-infected animals. Further, a combination staining was applied to evaluate the phe-
notype of cultured LR-MSCs. The detailed list of reagents used is summarized in S4 Table.
FCM acquisitions were performed using a BD FACS Canto II (BD Bioscience) using the DIVA
software and were further analysed with the FlowJo software version 10.6.0 (BD). Dead cells
were excluded by electronic gating in forward/side scatter plots, followed by exclusion of dou-
blets as well as LIVE/DEAD Fixable Dead Cell Staining (Invitrogen). Permeabilization and fix-
ation were undertaken according to the manufacturer’s protocol (BD and Invitrogen).
Trans-differentiation assay
For differentiation, pediatric LR-MSCs (passage 5) and ovine LR-MSCs (passage 3) were
plated in a 24-well plate in regular culture medium and placed in a humidified atmosphere at
37˚C with 5% CO2. After 48 hours, cells were washed with PBS and complete differentiation
media of the different StemPro Differentiation Kits (Thermofisher) was added. For adipogenic
induction cells were plated at 104 cells/cm2, for chondrogenic induction cells were plated at
2.7x104 cells/cm2, and to induce osteogenic differentiation, cells were plated at 5x103 cells/cm2.
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Medium was changed twice a week and after 15–21 days, cells were fixed with 4% PFA
(Sigma). Adipocytes were stained with Oil Red O (Sigma) to detect the formation of lipid
droplets and counterstained with hematoxylin (Carl Roth). Chondrocytes were stained with
Alcian Blue (Sigma) to visualize glycosaminoglycan synthesis and Alizarin Red S staining
(Sigma) was used to detect calcium deposits in osteocytes.
Microscopy analysis
Ovine BAL-derived MSCs and expanded pediatric LR-MSCs were cultured on a Nunc Lab-
Tek II Chamber Slide System with 50’000 cells per chamber (ThermoFisher). Next, the cells
were washed with cold PBS with Ca2+ and incubated with Wheat Germ Agglutinin (WGA)-
AF633 (ThermoFisher) for 10 min at 4˚C. Then, cells were fixed with 4% PFA for 10 min at
room temperature. Next, the cells were washed with 0.3% saponin (Sigma) and stained with
RSV-fusion protein antibody (Millipore) for 20 min at 4˚C. Then, 20 min incubation at 4˚C
with anti-mouse IgG2a-AF546 or -AF488 (both ThermoFisher) was applied. Finally, DAPI
(Sigma) was added for 5 min at 37˚C and cells were washed three times with cold PBS with
Ca2+ before mounting with MOWIOL 4–88 Reagent (Sigma). The detailed list of antibodies
used is summarized in S4 Table. Confocal microscopy analysis was performed with a Nikon
Eclipse Ti microscope (Nikon). All images were acquired using a 63X oil-immersion or a 40X
objective. The images were analyzed with IMARIS 7.7 software (Bitplane) with threshold sub-
traction and gamma correction. To monitor the spread of RSV-mCherry infection in
WD-AEC in comparison to MSC cultures, a Nikon BioStation CT was used (Nikon). The cul-
tures were followed over a period of 2 days with a 10X objective and images were acquired in
an automated sequence every 4 to 8 hours following infection. Reporter expression of RSV-
mCherry-infected pediatric LR-MSCs, ovine LR-MSCs, and RSV-GFP-infected ovine PCLS
was assessed using an Evos FL Auto 2 cell imaging system (ThermoFisher) or a Leica TCS-SL.
The micrographs from the trans-differentiation assays were captured using an inverted micro-
scope ECLIPSE TS100 with a Nikon DS-Fi3 camera using a DS-L4 application v.1.5.03 (all
from Nikon).
Immunoassays
When performing cytokine quantification, the supernatants and the basolateral medium from
RSV-A2 and RSV-ON1-H1 infections as well as of poly(I:C)-stimulated and unstimulated, and
mock-infected pediatric LR-MSCs and WD-AECs, respectively, were harvested after 24 and 72
h of culture at 37˚C with 5% CO2. Human IFN-β and IFN-λ1/3 concentrations were deter-
mined using commercial enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems)
following the manufacturer’s protocol. For the multiplex assay, the Pro Human Cytokine
27-plex Assay (Bio-Rad) was used according to the manufacturer’s protocol and read on a Bio-
Plex 3D suspension array system including a Bio-Plex Manager software v 6.0 (Bio-Rad).
Animals
Newborn lambs, males and females were allocated randomly to different groups (see below).
Before and during the experiment, they were kept with their ewes. In order to prevent second-
ary bacterial infections, the lambs received a prophylactic long-acting antibiotic treatment by
intramuscular injection of an oxytetracycline hydrochloride preparation (Cyclosol LA, 20 mg/
kg) starting at 18 to 24 h before RSV infection. The treatment was repeated 2 times with 4 days
interval. The trans-tracheal RSV inoculation was performed under sedation and analgesia by
intramuscular injection of a mixture of midazolam (Dormicum) 0.2 mg/kg and butorphanol
(Morphasol) 0.2 mg/kg. The trachea was punctured between the tracheal rings with a 0.9 x 40
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mm needle (20G) and a volume of 2 ml of virus (108 PFU) or PBS (mock-infected controls)
were injected. Body temperature, body weight and clinical status (respiratory and heart rates)
were assessed daily by a veterinarian, whenever possible by the same person to ensure unbiased
clinical assessment. At defined time points, namely at 3, 6, 14, and 42 days p.i., the lambs were
euthanized and examined for gross- and histopathology. The lung was processed for post-mor-
tem bronchoalveolar lavage.
Histopathological evaluation of lung tissue
Lung specimens were fixed in 4% buffered formalin for 48 h, embedded in paraffin and rou-
tinely processed for histology. Histological sections of 3 μm were stained with hematoxylin
and eosin coloration and observed by light microscopy. For immunohistochemistry, deparaffi-
nization of the sections was done with xylol for 5 minutes followed by rehydration in descend-
ing concentrations of ethanol (100, 95, 80, and 75%). H2O2 (3.25% in methanol, 10 min at
room temperature) inhibited endogenous peroxidase activity. Then, the slides were incubated
in boiling citrate buffer (pH 6.0) for 10 min for antigen retrieval. 1% BSA (10 min) was used
for blocking of nonspecific antibody binding, followed by an overnight incubation at 4˚C with
the primary antibody targeting RSV (ThermoFisher). For secondary antibody incubation and
signal detection LSAB and AEC Kits (DakoCytomation) were used following the manufactur-
ers protocol. Counterstaining was done with Ehrlich hematoxylin and cover slips were
mounted using Aquatex (Merck) [77].
Processing of lung tissue and bronchoalveolar lavage
One specimen per lung region (cranial, middle, and caudal) were pooled and dissociation was
done using a collagenase I and II and a DNase I enzyme mix (all from BioConcept) and the
gentleMACS Octo Dissociator (Miltenyi Biotec). Following this mechanical and enzymatical
dissociation, the samples were applied to a sieve, to remove any remaining particulate matter.
The cell suspensions were passed through cell strainers (100 and 70 μm pore-size, Falcon) and
centrifuged at 350g for 10 min at 4˚C to obtain single-cell suspensions. For the isolation of
cells from BALs, the lungs were isolated with the trachea, which was clamped before cutting, to
prevent blood from entering the lungs. Then, a PBS-containing antibiotic solution with 100
units/ml of penicillin and 100 μg/ml streptomycin (both Sigma), and 2.5 μg/ml Amphotericin
B was poured into the lungs through a sterile funnel (200–500 ml). The cell suspensions were
then passed through cell strainers (100 and 70 μm pore-size, Falcon) and centrifuged at 350g
for 10 min at 4˚C to obtain single cell suspensions. If needed, red blood cells were lysed by
resuspending the pellet with 2 ml of H2O and washed immediately in cold PBS before centrifu-
gation at 350g for 10 min at 4˚C. Cells were then processed for FCM analysis, CFU-F assay or
expanded in culture to obtain lung-derived MSCs. To isolate and expand MSCs in culture,
lung cell suspensions were seeded at a density of 3.5x104 cells per cm2 in tissue culture flasks as
described previously [3]. Cells were maintained in α-MEM (Thermofisher) supplemented
with 10% FBS (ThermoFisher), an antibiotic solution containing 100 units/ml of penicillin
and 100 μg/ml streptomycin, and 2.5 μg/ml Amphotericin B. After one to two days, the
medium was changed and cells were maintained at 37˚C with 5% CO2 until reaching ~80% of
confluence. Regular media changes were performed twice a week.
Colony-forming unit-fibroblast assay
Lung single-cell suspensions were seeded at a density of 3.5x104 cells per cm2 in a six-well plate
as described previously [3]. Cells were fixed after 7–14 days with ice-cold methanol for 20 min
and then washed with PBS. The cells were stained with Giemsa stain for 6 min, rinsed with
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H2O, and air-dried. Images were captured using an ImmunoSpot analyzer (CTL). Two experi-
enced investigators performed the CFU-F counts independently.
RNA isolation and mRNA sequencing and data analysis
For mRNA sequencing, total RNA was extracted from ovine LR-MSCs using TRIzol reagent
(ThermoFisher) in combination with the Nucleospin RNA Kit (Machery-Nagel) as previously
described [78]. In short, cells were lysed with 1 ml of TRIzol reagent and kept at -70˚C until
further processing. After thawing, 0.2 ml chloroform was added to the TRIzol lysate and the
samples were mixed vigorously and incubated for 2–3 min at room temperature. The extrac-
tions were then centrifuged at 12’000g for 15 min at 4˚C. The aqueous phase was collected and
mixed with 500 μl 75% ethanol and the RNA precipitated for 10 min at room temperature.
The RNA precipitate was further purified with the Nucleospin RNA kit according to the man-
ufacturer’s instructions. The quantity and quality of the extracted RNA was assessed using a
ThermoFisher Scientific Qubit 4.0 fluorometer with the Qubit RNA BR Assay Kit (Thermo
Fisher Scientific) and an Advanced Analytical Fragment Analyzer System using a Fragment
Analyzer RNA Kit (Agilent), respectively. Thereafter, cDNA libraries were generated using an
illumina TruSeq Stranded mRNA Library Prep (illumina) in combination with IDT for Illu-
mina–TruSeq RNA UD Indexes (Illumina). The illumina protocol was followed using the rec-
ommended input and quality of total RNA. The quantity and quality of the generated NGS
libraries were evaluated using a Thermo Fisher Scientific Qubit 4.0 fluorometer with the Qubit
dsDNA HS Assay Kit (ThermoFisher) and an Advanced Analytical Fragment Analyzer System
using a Fragment Analyzer NGS Fragment Kit (Agilent), respectively. The library pool was
paired end sequenced using a NovaSeq 6000 SP Reagent Kit v1.0, 100 cycles (illumina) on an
Illumina NovaSeq 6000 instrument. The quality of the sequencing runs was assessed using illu-
mina Sequencing Analysis Viewer (illumina version 2.4.7) and all base call files were demulti-
plexed and converted into FASTQ files using illumina bcl2fastq conversion software v2.20.
The average number of reads per library was 33.5 million. The RNA quality-control assess-
ments, generation of libraries and sequencing runs were performed at the Next Generation
Sequencing Platform, University of Bern, Switzerland. Analysis of the RNA-seq data was per-
formed at the Interfaculty Bioinformatics Unit at the University of Bern, Switzerland. RNAseq
data quality was assessed using fastqc v. 0.11.5 and RSeQC v. 2.6.4 [79]. The reads were
mapped to the Ovis aries reference genome (Oar_v3.1) with Hisat2 v.2.1.0 [80]. To count the
number of reads overlapping with each gene, as specified in the Ensembl annotation Feature-
Counts from Subread v.1.5.3 [81] was used. The Bioconductor package DESeq2 [82] was
applied to test for differential gene expression between the experimental groups. To evaluate
gene expression levels of MSC markers we applied the TPM normalization method [83]. The
molecular signatures database (MSigDB) with the Hallmark gene sets was used for GSEA [84].
Analysis was done using the Prism 8 software (GraphPad).
Statistical analysis
The Prism 8 software was used for statistical analysis. To determine differences between two
groups, non-parametric paired Wilcoxon test or Mann–Whitney U-test were used. For multi-
ple comparisons one-way ANOVA with Tukey post-hoc test or Kruskal-Wallis test with
Dunn’s correction were used. A p< 0.05 was considered statistically significant.
Supporting information
S1 Fig. Infection of pediatric LR-MSCs with RSV at a MOI of 1 PFU/cell. (A) RSV F-protein
positive LR-MSCs assessed by FCM and plotted over time. LR-MSCs were infected with 1
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PFU/cell with RSV-A2 (n = 3) or a clinical isolate RSV-ON1-H1 (n = 4–6). Each symbol repre-
sents an individual donor. (B) Supernatants of infected LR-MSCs or apical washes of infected
WD-AEC cultures were analyzed by a PFU assay. Cells were infected with RSV-ON1-H1 at a
MOI of 1 PFU/cell. A Mann-Whitney U test was applied to compare the two cell types
(WD-AECs, n = 3 versus LR-MSCs, n = 5–6). Each symbol represents an individual donor.
�p<0.05, ��p<0.01. (C) Intracellular infectious RSV titers over time in LR-MSCs infected with
RSV-A2 at 1 PFU/cell. Each symbol represents an individual donor (n = 3). (D) Extracellular
viral RNA loads over time in supernatants of infected LR-MSCs or apical washes of infected
WD-AEC cultures. Cells were infected with RSV-ON1-H1 at a MOI of 1 PFU/cell. A Mann-
Whitney U test was applied to compare the two cell types (WD-AECs, n = 3 versus LR-MSCs,
n = 4–6). Each symbol represents an individual donor. �p<0.05.
(TIFF)
S2 Fig. IFN mRNA levels and PD-L1 and MHC class I surface expression in RSV-infected
pediatric LR-MSCs. (A-C) mRNA levels of IFN-β (A), IFN-λ1 (B), and IFN-λ2/3 (C) in
LR-MSCs and WD-AECs infected with mock control or RSV-A2 at a MOI of 1 PFU/cell for 24
and 72 hours. Boxplots indicate the median value (centerline) and interquartile ranges
(box edges), with whiskers extending to the lowest and the highest values. Each symbol repre-
sents an individual donor (LR-MSCs, n = 4–6; WD-AECs, n = 3). The data were compared
with the Kruskal–Wallis test followed by Dunn’s post hoc test. (D) Representative histogram
of the surface expression of PD-L1 and MHC class I in pediatric LR-MSCs 24 h post-treatment
with mock, poly(I:C) 10 μg/ml, and RSV-A2 at 1 PFU/cell. (E) Median fluorescence intensity
(MFI) of PD-L1 and MHC class I expression. Each symbol represents an individual donor
(n = 3). The data were compared with the Kruskal–Wallis test followed by Dunn’s post hoc
test. �p<0.05.
(TIFF)
S3 Fig. RSV-infection of ovine PCLS and ovine LR-MSCs. (A) Representative histograms
showing expression of the surface markers CD29, CD44, and CD166. (B) Representative
phase-contrast (PC) micrograph showing morphology in culture and demonstrates plastic
adherence. Representative images of Toluidine blue, Alizarin Red S, and Oil Red O stainings
after chondrogenic (C), osteogenic (O), and adipogenic (A) differentiation, respectively. Mag-
nification 100X (PC, O), 200X (C, A). (C) Cell-associated RSV RNA loads expressed as RSV
copies per 109 18S copies (red empty circles) and infectious virus release in PFU per ml (blue
empty circles) over time following infection of primary ovine LR-MSCs with 0.1 PFU/cell of
RSV-A2 determined 24, 48, and 72 h p.i. Each symbol represents an individual donor (n = 3).
The positive control (P) is the virus preparation used for the infections having a titer of 2x107
PFU/ml. M, mock. (D-E) Ovine PCLS infected with RSV-GFP at 5x105 PFU per PCLS. Repre-
sentative fluorescence micrographs are shown at 72, 120, and 144 hours p.i. Scale bar, 650 μm
(D). Representative fluorescence micrographs indicating infection of pneumocytes. Scale bar,
125 μm (E).
(TIFF)
S4 Fig. Presence of potential syncytium in neonatal lungs following RSV infection. (A, B)
Representative histopathological sections of the lung tissue from lambs 6 days p.i. infected
with RSV-A2. The red and blue arrowheads indicate the presence of potential syncytia and the
green arrowheads indicate dome-shaped type 2 alveolar cells lining the alveolar wall, indicative
for type 2 alveolar cell hyperplasia. Scale bar, 50 μm.
(TIFF)
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S5 Fig. FCM assay for apoptosis detection in vivo. Gating strategy for the detection of cleaved
caspase-3-positive cells. G1, gate 1.
(TIFF)
S6 Fig. Infection of epithelial cells and LR-MSCs following neonatal RSV infection. RSV-
positive epithelial cells (Epith) and LR-MSCs in lung cell suspensions were detected with an
FCM assay 3, 6, 14, and 42 days following RSV-A2 infection of neonates. The dashed line
depicts the detection limits (0.6% for Epith and 0.8% for LR-MSCs). Boxplots indicate the
median value (centerline) and interquartile ranges (box edges), with whiskers extending to the
lowest and the highest values. Each symbol represents an individual animal (mock, n = 3–4;
RSV, n = 5–8).
(TIFF)
S7 Fig. Formation of syncytium upon RSV infection of human and ovine LR-MSCs. (A, B)
Representative micrographs of pediatric (A) and ovine (B) LR-MSCs infected with 0.1 PFU/
cell of RSV-mCherry 48–72 hours p.i. Giant multinucleated cells, indicative of syncytium for-
mation, were observed. Yellow arrowheads indicate clusters of nuclei and the yellow dashed
line indicates a giant multinucleated cell. PC, phase-contrast. Magnification 100X (PC, pediat-
ric LR-MSCs) and 400X (PC and RSV, ovine LR-MSCs). Scale bar, 125 μm.
(TIFF)
S1 Table. List of significant DEGs in RSV-infected versus mock-treated animals.
(DOCX)
S2 Table. Patient characteristics.
(DOCX)
S3 Table. List of qPCR primers.
(DOCX)
S4 Table. List of antibodies used.
(DOCX)
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